However, factors secreted by tumor cells, such as PTHrP, IL-1, and PGE2, have been shown to act on the bone matrix and stimulate osteoclast activity by simultaneously increasing RANKL expression and decreasing OPG expression [156]. The gene discussed is TNFSF11; the disease is neoplasm.